{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T22:58:35Z","timestamp":1782255515880,"version":"3.54.5"},"reference-count":58,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":3177,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1038\/modpathol.2013.185","type":"journal-article","created":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T08:55:03Z","timestamp":1383296103000},"page":"665-674","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Epidermal growth factor receptor signaling pathway is frequently altered in ampullary carcinoma at protein and genetic levels"],"prefix":"10.1016","volume":"27","author":[{"given":"Kaidi","family":"Mikhitarian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maressa","family":"Pollen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiguo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Shyr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nipun B","family":"Merchant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Revetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Kay","family":"Washington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Vnencak-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanjuan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.2013.185_bib1","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/PAS.0b013e31826399d8","article-title":"Ampullary region carcinomas: definition and site specific classification with delineation of four clinicopathologically and prognostically distinct subsets in an analysis of 249 cases","volume":"36","author":"Adsay","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2013.185_bib2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00042737-200012010-00014","article-title":"Cancer of the ampulla of Vater: results of a 20-year population-based study","volume":"12","author":"Benhamiche","year":"2000","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1038\/modpathol.2013.185_bib3","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1349-7006.1994.tb02077.x","article-title":"Different clinicopathologic findings in two histologic types of carcinoma of papilla of Vater","volume":"85","author":"Kimura","year":"1994","journal-title":"Jpn J Cancer Res"},{"key":"10.1038\/modpathol.2013.185_bib4","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1309\/AJCPCTCUQSYI89YT","article-title":"Phenotypic and genotypic characterization of carcinomas of the papilla of Vater has prognostic and putative therapeutic implications","volume":"135","author":"Kohler","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.2013.185_bib5","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/01.pas.0000149708.12335.6a","article-title":"Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2","volume":"29","author":"Chu","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2013.185_bib6","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00428-008-0669-7","article-title":"Immunophenotyping and oncogene amplifications in tumors of the papilla of Vater","volume":"453","author":"Baumhoer","year":"2008","journal-title":"Virchows Arch"},{"key":"10.1038\/modpathol.2013.185_bib7","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/00000478-200407000-00005","article-title":"Carcinoma of the ampulla of Vater: comparative histologic\/immunohistochemical classification and follow-up","volume":"28","author":"Zhou","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2013.185_bib8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00006676-200007000-00055","article-title":"Different amounts of K-ras mutant epithelial cells in pancreatic carcinoma and mass-forming pancreatitis","volume":"21","author":"Matsubayashi","year":"2000","journal-title":"Pancreas"},{"key":"10.1038\/modpathol.2013.185_bib9","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00428-007-0444-1","article-title":"Prognostic factors for ampullary adenocarcinomas: tumor stage, tumor histology, tumor location, immunohistochemistry and microsatellite instability","volume":"451","author":"Sessa","year":"2007","journal-title":"Virchows Arch"},{"key":"10.1038\/modpathol.2013.185_bib10","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00534-004-0898-3","article-title":"Pathogenesis of carcinoma of the papilla of Vater","volume":"11","author":"Fischer","year":"2004","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"10.1038\/modpathol.2013.185_bib11","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/jso.22090","article-title":"Clinical significance of pathologic subtype in curatively resected ampulla of vater cancer","volume":"105","author":"Kim","year":"2012","journal-title":"J Surg Oncol"},{"key":"10.1038\/modpathol.2013.185_bib12","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jamcollsurg.2008.01.028","article-title":"Tumors of the ampulla of vater: histopathologic classification and predictors of survival","volume":"207","author":"Carter","year":"2008","journal-title":"J Am Coll Surg"},{"issue":"Suppl 1","key":"10.1038\/modpathol.2013.185_bib13","first-page":"S87","article-title":"Epidermal growth factor receptor as a target in cancer therapy","volume":"1","author":"Kim","year":"2003","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1038\/modpathol.2013.185_bib14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1053\/sonc.2002.35643","article-title":"Epidermal growth factor receptor-targeted therapy in colorectal cancer","volume":"29","author":"O'Dwyer","year":"2002","journal-title":"Semin Oncol"},{"key":"10.1038\/modpathol.2013.185_bib15","first-page":"246","article-title":"Epidermal growth factor receptor as a therapeutic target in colorectal cancer","volume":"2","author":"Cohen","year":"2003","journal-title":"Clin Colorectal Cancer"},{"key":"10.1038\/modpathol.2013.185_bib16","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1002\/cncr.26661","article-title":"Epidermal growth factor receptor and insulinlike growth factor 1 receptor expression predict poor survival in pancreatic ductal adenocarcinoma","volume":"118","author":"Valsecchi","year":"2012","journal-title":"Cancer"},{"key":"10.1038\/modpathol.2013.185_bib17","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jss.2007.01.051","article-title":"EGFR genomic gain and aberrant pathway signaling in pancreatic cancer patients","volume":"143","author":"Tzeng","year":"2007","journal-title":"J Surg Res"},{"key":"10.1038\/modpathol.2013.185_bib18","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.cub.2011.03.043","article-title":"Amphiregulin exosomes increase cancer cell invasion","volume":"21","author":"Higginbotham","year":"2011","journal-title":"Curr Biol"},{"key":"10.1038\/modpathol.2013.185_bib19","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1111\/j.1349-7006.2010.01671.x","article-title":"Amphiregulin regulates the activation of ERK and Akt through epidermal growth factor receptor and HER3 signals involved in the progression of pancreatic cancer","volume":"101","author":"Yotsumoto","year":"2010","journal-title":"Cancer Sci"},{"key":"10.1038\/modpathol.2013.185_bib20","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.surg.2005.06.030","article-title":"Ligand-dependent activation of the epidermal growth factor receptor by secondary bile acids in polarizing colon cancer cells","volume":"138","author":"Merchant","year":"2005","journal-title":"Surgery"},{"key":"10.1038\/modpathol.2013.185_bib21","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1200\/JCO.2009.24.6116","article-title":"Molecular mechanisms of resistance to cetuximab and panitumumab in colorectal cancer","volume":"28","author":"Bardelli","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2013.185_bib22","doi-asserted-by":"crossref","first-page":"8017","DOI":"10.1038\/sj.onc.1208159","article-title":"Role of STATs as downstream signal transducers in Src family kinase-mediated tumorigenesis","volume":"23","author":"Silva","year":"2004","journal-title":"Oncogene"},{"key":"10.1038\/modpathol.2013.185_bib23","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1136\/gutjnl-2012-302423","article-title":"A combined oncogenic pathway signature of BRAF, KRAS and PI3KCA mutation improves colorectal cancer classification and cetuximab treatment prediction","volume":"62","author":"Sun","year":"2013","journal-title":"GUT"},{"key":"10.1038\/modpathol.2013.185_bib24","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S1470-2045(10)70130-3","article-title":"Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis","volume":"11","author":"De Roock","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1038\/modpathol.2013.185_bib25","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/j.ejca.2010.03.036","article-title":"Markers for EGFR pathway activation as predictor of outcome in metastatic colorectal cancer patients treated with or without cetuximab","volume":"46","author":"Tol","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1038\/modpathol.2013.185_bib26","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1038\/onc.2010.89","article-title":"Oncogenic mutations as predictive factors in colorectal cancer","volume":"29","author":"Lievre","year":"2010","journal-title":"Oncogene"},{"key":"10.1038\/modpathol.2013.185_bib27","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1158\/1078-0432.CCR-09-2446","article-title":"Prevalence and heterogeneity of KRAS, BRAF, and PIK3CA mutations in primary colorectal adenocarcinomas and their corresponding metastases","volume":"16","author":"Baldus","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2013.185_bib28","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1007\/s00428-006-0191-8","article-title":"Molecular analysis of the EGFR-RAS-RAF pathway in pancreatic ductal adenocarcinomas: lack of mutations in the BRAF and EGFR genes","volume":"448","author":"Immervoll","year":"2006","journal-title":"Virchows Arch"},{"key":"10.1038\/modpathol.2013.185_bib29","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s004280100474","article-title":"Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and DPC4\/Smad4","volume":"439","author":"Moore","year":"2001","journal-title":"Virchows Arch"},{"key":"10.1038\/modpathol.2013.185_bib30","first-page":"71","article-title":"Inactivation of both alleles of the DPC4\/SMAD4 gene in advanced colorectal cancers: identification of seven novel somatic mutations in tumors from Japanese patients","volume":"406","author":"Koyama","year":"1999","journal-title":"Mutat Res"},{"issue":"Suppl 4","key":"10.1038\/modpathol.2013.185_bib31","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/annonc\/10.suppl_4.S56","article-title":"DPC4\/SMAD4 gene alterations in human cancer, and their functional implications","volume":"10","author":"Schutte","year":"1999","journal-title":"Ann Oncol"},{"key":"10.1038\/modpathol.2013.185_bib32","doi-asserted-by":"crossref","first-page":"9719","DOI":"10.1073\/pnas.171321498","article-title":"SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway","volume":"98","author":"Woodford-Richens","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/modpathol.2013.185_bib33","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jmoldx.2010.11.010","article-title":"A platform for rapid detection of multiple oncogenic mutations with relevance to targeted therapy in non-small-cell lung cancer","volume":"13","author":"Su","year":"2011","journal-title":"J Mol Diagn"},{"key":"10.1038\/modpathol.2013.185_bib34","unstructured":"Team RDC. A Language and Environment for Statistical Computing. R Foundation for Statistical Computing: Vienna, Austria, 2012."},{"key":"10.1038\/modpathol.2013.185_bib35","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s11605-010-1156-4","article-title":"Lymph node involvement and not the histophatologic subtype is correlated with outcome after resection of adenocarcinoma of the ampulla of vater","volume":"14","author":"de Paiva Haddad","year":"2010","journal-title":"J Gastrointest Surg"},{"key":"10.1038\/modpathol.2013.185_bib36","first-page":"2315","article-title":"Amphiregulin is a prognostic factor in colorectal cancer","volume":"32","author":"Ohchi","year":"2012","journal-title":"Anticancer Res"},{"key":"10.1038\/modpathol.2013.185_bib37","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1158\/1078-0432.CCR-07-4499","article-title":"Amphiregulin is a promising prognostic marker for liver metastases of colorectal cancer","volume":"14","author":"Yamada","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2013.185_bib38","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1159\/000315380","article-title":"Amphiregulin and epiregulin expression in colorectal carcinoma and the correlation with clinicopathological characteristics","volume":"33","author":"Li","year":"2010","journal-title":"Onkologie"},{"key":"10.1038\/modpathol.2013.185_bib39","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1471-2407-12-88","article-title":"Amphiregulin and Epiregulin mRNA expression in primary colorectal cancer and corresponding liver metastases","volume":"12","author":"Kuramochi","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1038\/modpathol.2013.185_bib40","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1200\/JCO.2006.10.5437","article-title":"Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab","volume":"25","author":"Khambata-Ford","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2013.185_bib41","doi-asserted-by":"crossref","first-page":"18301","DOI":"10.1074\/jbc.M110.215707","article-title":"The human adenocarcinoma-associated gene, AGR2, induces expression of amphiregulin through Hippo pathway co-activator YAP1 activation","volume":"286","author":"Dong","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1038\/modpathol.2013.185_bib42","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.bbrc.2007.11.015","article-title":"Validation of HB-EGF and amphiregulin as targets for human cancer therapy","volume":"365","author":"Yotsumoto","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/modpathol.2013.185_bib43","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1245\/s10434-012-2277-7","article-title":"Postoperative prognostic predictors of pancreatic ductal adenocarcinoma: clinical analysis and immunoprofile on tissue microarrays","volume":"19","author":"Park","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1038\/modpathol.2013.185_bib44","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/sj.bjc.6605473","article-title":"Prognostic effect of activated EGFR expression in human colon carcinomas: comparison with EGFR status","volume":"102","author":"Rego","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1038\/modpathol.2013.185_bib45","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1245\/ASO.2006.05.052","article-title":"Prognostic significance of epidermal growth factor receptor expression in colon cancer patients undergoing curative surgery","volume":"13","author":"Galizia","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"10.1038\/modpathol.2013.185_bib46","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.humpath.2012.11.006","article-title":"Molecular profiling of cholangiocarcinoma shows potential for targeted therapy treatment decisions","volume":"44","author":"Voss","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2013.185_bib47","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1200\/JCO.2009.27.4787","article-title":"Genetics of biliary tract cancers and emerging targeted therapies","volume":"28","author":"Hezel","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2013.185_bib48","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1471-2407-11-60","article-title":"Mutational profiling reveals PIK3CA mutations in gallbladder carcinoma","volume":"11","author":"Deshpande","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1038\/modpathol.2013.185_bib49","first-page":"3497","article-title":"Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique","volume":"51","author":"Levi","year":"1991","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2013.185_bib50","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/PPO.0b013e31827459b6","article-title":"Pathology and molecular genetics of pancreatic neoplasms","volume":"18","author":"Wood","year":"2012","journal-title":"Cancer J"},{"key":"10.1038\/modpathol.2013.185_bib51","first-page":"620601","article-title":"Molecular characteristics of pancreatic ductal adenocarcinoma","volume":"2011","author":"Ottenhof","year":"2011","journal-title":"Patholog Res Int"},{"key":"10.1038\/modpathol.2013.185_bib52","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1101\/gad.1415606","article-title":"Genetics and biology of pancreatic ductal adenocarcinoma","volume":"20","author":"Hezel","year":"2006","journal-title":"Genes Dev"},{"key":"10.1038\/modpathol.2013.185_bib53","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/MPA.0b013e31823cd9df","article-title":"Frequencies and prognostic role of KRAS and BRAF mutations in patients with localized pancreatic and ampullary adenocarcinomas","volume":"41","author":"Schultz","year":"2012","journal-title":"Pancreas"},{"key":"10.1038\/modpathol.2013.185_bib54","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1007\/s11605-009-0917-4","article-title":"Molecular analysis of PIK3CA, BRAF, and RAS oncogenes in periampullary and ampullary adenomas and carcinomas","volume":"13","author":"Schonleben","year":"2009","journal-title":"J Gastrointest Surg"},{"key":"10.1038\/modpathol.2013.185_bib55","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1097\/01.MP.0000036450.61830.8E","article-title":"Invasive papillary carcinomas of the extrahepatic bile ducts: a clinicopathologic and immunohistochemical study of 13 cases","volume":"15","author":"Hoang","year":"2002","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2013.185_bib56","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1158\/1055-9965.EPI-12-0674","article-title":"BRAF mutation status and survival after colorectal cancer diagnosis according to patient and tumor characteristics","volume":"21","author":"Phipps","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1038\/modpathol.2013.185_bib57","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1158\/1535-7163.MCT-12-0290","article-title":"Molecular profiling of patients with colorectal cancer and matched targeted therapy in phase I clinical trials","volume":"11","author":"Dienstmann","year":"2012","journal-title":"Mol Cancer Ther"},{"key":"10.1038\/modpathol.2013.185_bib58","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nature10868","article-title":"Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR","volume":"483","author":"Prahallad","year":"2012","journal-title":"Nature"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/modpathol2013185.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2013185","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222035803?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222035803?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2013185.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T01:12:27Z","timestamp":1760231547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222035803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":58,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0893395222035803"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.2013.185","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidermal growth factor receptor signaling pathway is frequently altered in ampullary carcinoma at protein and genetic levels","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2013.185","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2014 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}